90 related articles for article (PubMed ID: 23715961)
21. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
[TBL] [Abstract][Full Text] [Related]
22. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
[TBL] [Abstract][Full Text] [Related]
23. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
24. Influence of socioeconomic status on distance traveled and care after stroke.
Ahuja C; Mamdani M; Saposnik G;
Stroke; 2012 Jan; 43(1):233-5. PubMed ID: 21980198
[TBL] [Abstract][Full Text] [Related]
25. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers.
Yoneda Y; Okuda S; Hamada R; Toyota A; Gotoh J; Watanabe M; Okada Y; Ikeda K; Ibayashi S; Hasegawa Y
Health Policy; 2005 Aug; 73(2):202-11. PubMed ID: 15978963
[TBL] [Abstract][Full Text] [Related]
26. Cost and Outcome in Pediatric Ischemic Stroke.
Hamilton W; Huang H; Seiber E; Lo W
J Child Neurol; 2015 Oct; 30(11):1483-8. PubMed ID: 25660132
[TBL] [Abstract][Full Text] [Related]
27. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
Pinzón JF; Maldonado C; Díaz JA; Segura O
Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
[TBL] [Abstract][Full Text] [Related]
28. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
Leppert MH; Campbell JD; Simpson JR; Burke JF
Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
[TBL] [Abstract][Full Text] [Related]
30. The hospital costs of care for stroke in nine European countries.
Epstein D; Mason A; Manca A
Health Econ; 2008 Jan; 17(1 Suppl):S21-31. PubMed ID: 18186037
[TBL] [Abstract][Full Text] [Related]
31. Quality of care and outcomes for in-hospital ischemic stroke: findings from the National Get With The Guidelines-Stroke.
Cumbler E; Wald H; Bhatt DL; Cox M; Xian Y; Reeves M; Smith EE; Schwamm L; Fonarow GC
Stroke; 2014 Jan; 45(1):231-8. PubMed ID: 24253540
[TBL] [Abstract][Full Text] [Related]
32. Cost of acute ischemic and hemorrhagic stroke in Turkey.
Asil T; Celik Y; Sut N; Celik AD; Balci K; Yilmaz A; Karaduman F
Clin Neurol Neurosurg; 2011 Feb; 113(2):111-4. PubMed ID: 21036465
[TBL] [Abstract][Full Text] [Related]
33. The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada.
Caro JJ; Migliaccio-Walle K; Ishak KJ; Proskorovsky I; O'Brien JA
BMC Health Serv Res; 2006 Aug; 6():99. PubMed ID: 16907982
[TBL] [Abstract][Full Text] [Related]
34. Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in Croatia.
Matijević V; Poljaković Z; Malojčić B; Mišmaš A; Bazina A; Boban M; Bilić I; Radanović B; Glavor KD; Kiđemet-Piskač S; Habek M
J Neurol Sci; 2012 Mar; 314(1-2):126-9. PubMed ID: 22063080
[TBL] [Abstract][Full Text] [Related]
35. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
36. The future cost of stroke in Ireland: an analysis of the potential impact of demographic change and implementation of evidence-based therapies.
Smith S; Horgan F; Sexton E; Cowman S; Hickey A; Kelly P; McGee H; Murphy S; O'Neill D; Royston M; Shelley E; Wiley M
Age Ageing; 2013 May; 42(3):299-306. PubMed ID: 23302602
[TBL] [Abstract][Full Text] [Related]
37. Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007.
Hoh BL; Chi YY; Waters MF; Mocco J; Barker FG
Stroke; 2010 Oct; 41(10):2323-8. PubMed ID: 20724715
[TBL] [Abstract][Full Text] [Related]
38. Representativeness of the Get With The Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke.
Reeves MJ; Fonarow GC; Smith EE; Pan W; Olson D; Hernandez AF; Peterson ED; Schwamm LH
Stroke; 2012 Jan; 43(1):44-9. PubMed ID: 21980197
[TBL] [Abstract][Full Text] [Related]
39. An analysis of the costs of ischemic stroke in an Italian stroke unit.
Mamoli A; Censori B; Casto L; Sileo C; Cesana B; Camerlingo M
Neurology; 1999 Jul; 53(1):112-6. PubMed ID: 10408545
[TBL] [Abstract][Full Text] [Related]
40. Costs of stroke using patient-level data: a critical review of the literature.
Luengo-Fernandez R; Gray AM; Rothwell PM
Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
